• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Acentra Health Awarded $27.5 Million Contract from California Medicaid to Continue Providing Preadmission Screening and Resident Review (PASRR) Services

    4/29/25 9:34:00 AM ET
    $CG
    Investment Managers
    Finance
    Get the next $CG alert in real time by email

    MCLEAN, Va., April 29, 2025 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, today announced it has been awarded a two-year $27.5 million contract, with one option year, from the California Department of Health Care Services (DHCS) to continue delivering Level I initial screenings and Level II evaluations for serious mental illness as part of the state's Preadmission Screening and Resident Review (PASRR) program for long-term care.

    The new contract, awarded through a competitive procurement process, builds on the company's work as a trusted partner delivering PASRR and other services for California Medicaid since 2015.

    PASRR is a federally mandated screening process that determines if applicants to Medicaid-certified long-term care nursing facilities have a serious mental illness, intellectual disability, developmental disability, or related condition. Individuals identified as having one or more of these conditions undergo a PASRR Level II evaluation to ensure they receive services in the least restrictive settings possible.

    "We are honored to be selected again by the California Department of Health Care Services as their vital partner for PASRR services and applaud their efforts to protect and support individuals with complex behavioral health needs," said Todd Stottlemyer, Acentra Health CEO. "Acentra Health is proud of our 23-year history providing PASRR services nationwide and sees this award as a reflection of our proven track record for delivering impactful, value-driven solutions for all our PASRR clients."

    California operates the largest PASRR program in the nation, with Acentra Health conducting approximately 233,000 initial screenings and 18,000 Level II evaluations for the state each year. Since the initial contract began, Acentra Health has partnered with DHCS to streamline clinical workflows and improve program efficiencies, aligning with California's commitment to fiscal responsibility and program integrity. These innovations have helped California achieve some of the nation's fastest PASRR turnaround times – averaging fewer than two calendar days across all assessments – well below federal benchmarks.

    The California award follows the recent addition of two states to Acentra Health's PASRR portfolio, expanding the company's footprint to eight states. The company was selected to provide PASRR Level II assessments by the Kansas Department of Health and Environment, with an effective go-live of April 1, 2025, and by the Washington State Health Care Authority, with an effective go-live of July 1, 2024.

    Acentra Health has more than 30 years of experience evaluating and assessing the medical necessity needs for Medicaid program beneficiaries. As part of its PASRR services, the company delivers reliable, timely, and clinically valid recommendations and determinations that protect the interests of individuals while ensuring state compliance with federal requirements. Acentra Health's services include Level I screening, Level II evaluation, determination and notification processing, a comprehensive PASRR IT system, and extensive daily and monthly reporting.

    About Acentra Health

    Acentra Health combines public sector knowledge, clinical expertise, and technological ingenuity to modernize the healthcare experience for state, federal, and commercial partners, and their priority populations. From designing and developing advanced claims, encounter, and provider solutions that drive efficiency and cost savings to delivering clinically focused service models for care management, clinical assessments, and quality oversight, Acentra Health is accelerating better health outcomes. Acentra Health is backed by Carlyle (NASDAQ:CG), a global investment firm. Learn more at acentra.com.

    Media Contact:

    Janice Moore

    Vice President, Corporate Communications

    703-214-3552



    Primary Logo

    Get the next $CG alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CG

    DatePrice TargetRatingAnalyst
    2/24/2026$67.00Outperform
    RBC Capital Mkts
    12/11/2025$74.00Buy
    UBS
    10/3/2025$74.00Outperform
    BMO Capital Markets
    7/10/2025$65.00Neutral → Buy
    Citigroup
    5/14/2025$56.00Hold → Buy
    TD Cowen
    3/19/2025Outperform → Perform
    Oppenheimer
    1/3/2025$60.00Peer Perform → Outperform
    Wolfe Research
    9/12/2024$42.00Equal Weight
    Wells Fargo
    More analyst ratings

    $CG
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by The Carlyle Group Inc.

    SCHEDULE 13G/A - Carlyle Group Inc. (0001527166) (Subject)

    3/26/26 4:44:46 PM ET
    $CG
    Investment Managers
    Finance

    SEC Form 10-K filed by The Carlyle Group Inc.

    10-K - Carlyle Group Inc. (0001527166) (Filer)

    2/27/26 4:13:57 PM ET
    $CG
    Investment Managers
    Finance

    The Carlyle Group Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Carlyle Group Inc. (0001527166) (Filer)

    2/26/26 7:00:39 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    RBC Capital Mkts initiated coverage on Carlyle Group with a new price target

    RBC Capital Mkts initiated coverage of Carlyle Group with a rating of Outperform and set a new price target of $67.00

    2/24/26 7:47:48 AM ET
    $CG
    Investment Managers
    Finance

    UBS resumed coverage on Carlyle Group with a new price target

    UBS resumed coverage of Carlyle Group with a rating of Buy and set a new price target of $74.00

    12/11/25 9:06:22 AM ET
    $CG
    Investment Managers
    Finance

    BMO Capital Markets initiated coverage on Carlyle Group with a new price target

    BMO Capital Markets initiated coverage of Carlyle Group with a rating of Outperform and set a new price target of $74.00

    10/3/25 8:37:30 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Rubenstein David M.

    4 - Carlyle Group Inc. (0001527166) (Issuer)

    3/20/26 5:34:13 PM ET
    $CG
    Investment Managers
    Finance

    Large owner Carlyle Group Inc. sold $1,070,339,440 worth of shares (26,105,840 units at $41.00) and disposed of 2,113,483 shares (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Reporting)

    3/12/26 4:30:20 PM ET
    $CG
    Investment Managers
    Finance

    Large owner Carlyle Group Inc. converted options into 9,297,883 shares and disposed of 9,297,883 units of Class B Common Stock (SEC Form 4)

    4 - Carlyle Group Inc. (0001527166) (Reporting)

    3/6/26 7:02:25 PM ET
    $CG
    Investment Managers
    Finance

    $CG
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    YipitData Appoints ZoomInfo Founder and CEO Henry Schuck to Board of Directors to Support Next Phase of Growth

    Schuck brings deep expertise in scaling data-driven technology platforms and building category-defining companies YipitData, the leading provider of alternative data-driven market intelligence for institutional investors, retailers, consumer brands, and enterprises, today announced that Henry Schuck, Founder and Chief Executive Officer of ZoomInfo (NASDAQ:GTM), has joined its Board of Directors. Schuck brings more than two decades of experience building and scaling data-driven technology platforms. He founded ZoomInfo in 2007 and led its transformation from an early-stage startup into a category-defining B2B intelligence platform, culminating in a successful public listing. Under his le

    4/13/26 9:00:00 AM ET
    $CG
    $GTM
    Investment Managers
    Finance
    Computer Software: Prepackaged Software
    Technology

    Carlyle to Announce First Quarter 2026 Financial Results and Host Investor Conference Call

    WASHINGTON and NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- The Carlyle Group Inc. (NASDAQ:CG) announced today that it will release financial results for the first quarter 2026 on Thursday, May 7, 2026, and host a conference call at 8:30 a.m. EDT. The conference call will be available via public webcast from the Events & Presentations section of ir.carlyle.com and a replay will also be available after the call's completion. Chief Executive Officer Harvey Schwartz, along with Chief Financial Officer Justin Plouffe and Head of Public Investor Relations Daniel Harris, will review the results during the call. The earnings release will be available through all Carlyle channels, including the

    4/9/26 10:05:31 AM ET
    $CG
    Investment Managers
    Finance

    Acentra Health Named to Newsweek's Greatest Workplaces for Entry Level 2026 List

    MCLEAN, Va., April 08, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions company dedicated to accelerating better health outcomes for government and commercial clients and the populations they serve, today announced it has been named to Newsweek's "America's Greatest Workplaces for Entry Level" 2026, a prestigious recognition honoring organizations that excel in supporting employees at the start of their careers. The award, presented by Newsweek in partnership with Plant-A Insights Group, is based on one of the largest independent workforce studies in the U.S. The ranking evaluates companies with more than 1,000 employees using a combination of a large-scale natio

    4/8/26 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    Leadership Updates

    Live Leadership Updates

    View All

    YipitData Appoints ZoomInfo Founder and CEO Henry Schuck to Board of Directors to Support Next Phase of Growth

    Schuck brings deep expertise in scaling data-driven technology platforms and building category-defining companies YipitData, the leading provider of alternative data-driven market intelligence for institutional investors, retailers, consumer brands, and enterprises, today announced that Henry Schuck, Founder and Chief Executive Officer of ZoomInfo (NASDAQ:GTM), has joined its Board of Directors. Schuck brings more than two decades of experience building and scaling data-driven technology platforms. He founded ZoomInfo in 2007 and led its transformation from an early-stage startup into a category-defining B2B intelligence platform, culminating in a successful public listing. Under his le

    4/13/26 9:00:00 AM ET
    $CG
    $GTM
    Investment Managers
    Finance
    Computer Software: Prepackaged Software
    Technology

    Acentra Health Names New Senior Vice Presidents, Mohamed Karama and Nirav Dalal, to Drive Company Growth and Business Development

    MCLEAN, Va., March 25, 2026 (GLOBE NEWSWIRE) -- Acentra Health, a technology and health solutions and services company dedicated to accelerating better outcomes for its government and commercial healthcare clients and the populations they serve, announced today that Mohamed Karama has joined the company as Senior Vice President of Growth Acceleration and Performance, and Nirav Dalal has been promoted to Senior Vice President of Sales Leadership. These appointments advance Acentra Health's transformation initiatives and position the company for strategic growth. "As we continue transforming Acentra Health, we're investing in our growth engine," said Patty Obermaier, EVP, Chief Growth Offic

    3/25/26 9:33:00 AM ET
    $CG
    Investment Managers
    Finance

    Carlyle to Host 2026 Shareholder Update

    WASHINGTON and NEW YORK, Feb. 02, 2026 (GLOBE NEWSWIRE) -- Global investment firm Carlyle (NASDAQ:CG) announced today that it will host a Shareholder Update on Thursday, February 26, 2026. The Shareholder Update will include a series of presentations by the company's senior leadership team and will review Carlyle's growth outlook and financial objectives. Presentations will begin at 8:30 a.m. EST, followed by a Q&A session. Presentation materials and a live webcast will be posted on the day of the event and can be accessed on the Events & Presentations section of ir.carlyle.com. For those unable to join the live webcast, a replay will be available on the website following the event. Any

    2/2/26 8:01:00 AM ET
    $CG
    Investment Managers
    Finance

    $CG
    Financials

    Live finance-specific insights

    View All

    Carlyle to Announce First Quarter 2026 Financial Results and Host Investor Conference Call

    WASHINGTON and NEW YORK, April 09, 2026 (GLOBE NEWSWIRE) -- The Carlyle Group Inc. (NASDAQ:CG) announced today that it will release financial results for the first quarter 2026 on Thursday, May 7, 2026, and host a conference call at 8:30 a.m. EDT. The conference call will be available via public webcast from the Events & Presentations section of ir.carlyle.com and a replay will also be available after the call's completion. Chief Executive Officer Harvey Schwartz, along with Chief Financial Officer Justin Plouffe and Head of Public Investor Relations Daniel Harris, will review the results during the call. The earnings release will be available through all Carlyle channels, including the

    4/9/26 10:05:31 AM ET
    $CG
    Investment Managers
    Finance

    Carlyle Presents Growth Outlook at 2026 Shareholder Update

    WASHINGTON and NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- Global investment firm Carlyle (NASDAQ:CG) is announcing its growth outlook and financial objectives at the 2026 Shareholder Update, beginning today at 8:30 a.m. EST. The program will include presentations by senior leadership, followed by a Q&A session. Carlyle will announce three-year financial targets to be achieved by the end of 2028, including: FRE of $1.9+ billionInflows of $200+ billionDE per common share of $6.00+ Carlyle is also announcing that its Board of Directors has approved a new $2 billion share repurchase authorization. The authorization provides the firm with flexibility to repurchase shares as part of its disc

    2/26/26 7:01:00 AM ET
    $CG
    Investment Managers
    Finance

    Carlyle Secured Lending, Inc. Announces Financial Results For Fourth Quarter and Full Year Ended December 31, 2025, Declares First Quarter 2026 Dividend of $0.40 Per Common Share

    NEW YORK, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Carlyle Secured Lending, Inc. (together with its consolidated subsidiaries, "we," "us," "our," "CGBD" or the "Company") (NASDAQ:CGBD) today announced its financial results for its fourth quarter and full year ended December 31, 2025. Alex Chi, CGBD's Chief Executive Officer, said, "As CGBD's newly appointed CEO, I look forward to continuing to build on Carlyle's strong track record and world-class platform. Building off record origination volume in the fourth quarter and full year 2025, we continue to expand our origination apparatus and are focused on further harnessing the full power of the OneCarlyle platform. The depth of our underwriting se

    2/24/26 4:05:00 PM ET
    $CG
    $CGBD
    Investment Managers
    Finance
    Finance: Consumer Services

    $CG
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Subject)

    11/15/24 5:22:29 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

    10/21/24 4:31:27 PM ET
    $CG
    Investment Managers
    Finance

    Amendment: SEC Form SC 13D/A filed by The Carlyle Group Inc.

    SC 13D/A - Carlyle Group Inc. (0001527166) (Filed by)

    10/15/24 4:31:27 PM ET
    $CG
    Investment Managers
    Finance